S. 5130 · 118th Congress · Crime and Law Enforcement

Opioid Overdose Data Collection Enhancement Act

Died in the House583 words Introduced Sep 19, 2024 · Latest action Dec 18, 2024

How far it has goneStopped at 4 of 6 · Died in the House
  1. IntroducedSep 19, 2024 Done
  2. CommitteeDischarged Dec 17, 2024 Done
  3. Senate floorPassed by unanimous consent · Dec 17, 2024 Done
  4. House floorDied Jan 3, 2025 Stopped here
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill expands the allowable uses of grants under the Comprehensive Opioid Abuse Grant Program to include the adoption and implementation of an overdose data collection program to track fatal and nonfatal overdoses and the administration of opioid overdose reversal medication (e.g., the Overdose Detection Mapping Application Program).

Specifically, the bill allows states, local governments, coalitions of law enforcement agencies, and Indian tribes to use these grants to develop and implement a data collection tool, including mobile data mapping applications. The tool must allow these entities to easily and quickly track the locations of (1) suspected fatal and nonfatal overdoses, and (2) the administration of opioid overdose reversal medication by first responders.

An entity seeking to use a grant must first conduct an audit of available data and resources and submit the audit with the grant application.

Grant recipients must (1) support the development of coordinated public safety, behavioral health, and public health responses to the data collected by the tool; (2) focus on areas in which fatal and nonfatal overdoses occur and trends of concern; (3) provide for interoperability with existing overdose data collection tools; and (4) make data collected through the program available to federal, state, tribal, and territorial governments and coalitions of law enforcement agencies.

The Department of Justice must consult with agencies that maintain overdose data collection tools, including the Office of National Drug Control Policy.

Congressional Research Service · summary of “Passed Senate” version · Dec 17, 2024

Who lobbies on it

No lobbying filing on file names S. 5130.

Organizations that named S. 5130 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

8 actions · newest first
  1. Dec 18, 2024Held at the desk.
  2. Dec 18, 2024Received in the House.
  3. Dec 18, 2024Message on Senate action sent to the House.
  4. Dec 17, 2024Passed Senate without amendment by Unanimous Consent. (consideration: CR S7096-7097; text: CR S7096-7097)
Show all 8 actionsShow fewer
  1. Dec 17, 2024Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
  2. Dec 17, 2024Senate Committee on the Judiciary discharged by Unanimous Consent.
  3. Sep 19, 2024Read twice and referred to the Committee on the Judiciary.
  4. Sep 19, 2024Introduced in Senate